We are live on ! Find out more
WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$2.13B
AUM Growth
-$60.6M
Cap. Flow
-$152M
Cap. Flow %
-7.14%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
4
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$43.9M
2
TBPH icon
Theravance Biopharma
TBPH
+$41.2M
3
ABBV icon
AbbVie
ABBV
+$36.2M
4
ALKS icon
Alkermes
ALKS
+$16.7M
5
BIIB icon
Biogen
BIIB
+$5.27M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$295M

Sector Composition

Rank Sector Weight
1 Healthcare 76.38%
2 Consumer Staples 23.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$431B
$722M 33.91%
11,656,800
+593,500
+5% +$36.2M
RAI
2
DELISTED
Reynolds American Inc
RAI
$503M 23.62%
9,322,463
-5,873,650
-39% -$295M
PRTA icon
3
Prothena Corp
PRTA
$449M
$360M 16.93%
10,304,751
+1,008,390
+11% +$43.9M
ALKS icon
4
Alkermes
ALKS
$8.11B
$326M 15.3%
7,535,533
+404,000
+6% +$16.7M
TBPH icon
5
Theravance Biopharma
TBPH
$877M
$198M 9.31%
8,733,637
+1,909,000
+28% +$41.2M
NWBO
6
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$15.1M 0.71%
25,915,937
– –
BIIB icon
7
Biogen
BIIB
$30.5B
$4.84M 0.23%
+20,000
New +$5.27M

Similar funds

LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 2.79% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return

Woodford Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Woodford Investment Management held 7 positions worth $2.13B, down 2.8% from $2.19B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Woodford Investment Management withdrew a net $152M in Q2 2016, reducing 1 holding. Its largest reduction was Reynolds American Inc, cutting an estimated $295M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 65% a quarter earlier, followed by Consumer Staples.

Against the trend, Woodford Investment Management opened a new position in Biogen worth $4.84M.

  • Woodford Investment Management's largest Q2 2016 buy was Biogen: 20,000 shares worth $4.84M.
  • Woodford Investment Management added most to Prothena Corp in Q2 2016, an estimated $43.9M increase.
  • Woodford Investment Management's biggest Q2 2016 reduction was Reynolds American Inc, cutting an estimated $295M.
  • Woodford Investment Management's ten largest holdings make up 100% of its $2.13B portfolio in Q2 2016.
  • Woodford Investment Management opened 1 new position and closed 0 in Q2 2016.
  • Woodford Investment Management's portfolio value fell 2.8% quarter-over-quarter to $2.13B.

Based on Woodford Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.